1.
Hadeel Delman Najim, Mohammed Mahmood Mohammed, Abbas Mahdi Rahmah. Influence of Adding Empagliflozin to Conventional Anti-diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2024 Sep. 15 [cited 2025 Apr. 3];33(3):142-9. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2742